Abiomed (ABMD) Short Interest Ratio & Short Volume → $25,000 into $109,616 in two months? (From WealthPress) (Ad) Free ABMD Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Abiomed Short Interest DataCurrent Short Volume753,600 sharesPrevious Short Volume667,400 sharesChange Vs. Previous Month+12.92%Dollar Volume Sold Short$284.70 millionShort Interest Ratio / Days to Cover0.8Last Record DateNovember 30, 2022Outstanding Shares45,091,000 sharesFloat Size44,160,000 sharesShort Percent of Float1.71%Today's Trading Volume258 sharesAverage Trading Volume611,028 sharesToday's Volume Vs. Average0% Short Selling Abiomed ? Sign up to receive the latest short interest report for Abiomed and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatABMD Short Interest Over TimeABMD Days to Cover Over TimeABMD Percentage of Float Shorted Over Time Ad The TradingPubAt first glance, this chart looks like nonsense…We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates”But if you want the stock with “Hotspot Dates” hitting NEXT WEEK… Abiomed Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/2022753,600 shares $284.70 million +12.9%1.7%0.8 $377.79 11/15/2022667,400 shares $249.74 million -67.9%1.5%0.8 $374.20 10/31/20222,080,000 shares $524.33 million +5.6%4.7%3.8 $252.08 10/15/20221,970,000 shares $491.08 million +17.3%4.4%7.2 $249.28 9/30/20221,680,000 shares $412.71 million +5.7%3.8%6.3 $245.66 9/15/20221,590,000 shares $419.31 million -3.6%3.6%6 $263.72 Get the Latest News and Ratings for ABMD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Abiomed and its competitors with MarketBeat's FREE daily newsletter. 8/31/20221,650,000 shares $427.81 million +6.5%3.7%6.2 $259.28 8/15/20221,550,000 shares $457.34 million -9.4%3.5%5.7 $295.06 7/31/20221,710,000 shares $501.05 million -3.4%3.8%5.6 $293.01 7/15/20221,770,000 shares $474.77 million +6.0%4.0%5.6 $268.23 6/30/20221,670,000 shares $413.34 million -2.9%3.8%5.3 $247.51 6/15/20221,720,000 shares $399.64 million +4.9%3.9%5.5 $232.35 5/31/20221,640,000 shares $432.47 million +7.2%3.7%5.5 $263.70 5/15/20221,530,000 shares $388.86 million +36.6%3.4%5.2 $254.16 4/30/20221,120,000 shares $320.97 million -12.5%2.5%3.7 $286.58 4/15/20221,280,000 shares $391.78 million +1.6%2.9%3.8 $306.08 3/31/20221,260,000 shares $417.36 million +1.6%2.8%3.3 $331.24 3/15/20221,240,000 shares $359.15 million -2.4%2.8%3.3 $289.64 2/28/20221,270,000 shares $394.64 million +11.4%2.9%3.3 $310.74 2/15/20221,140,000 shares $347.36 million -0.9%2.6%3 $304.70 1/31/20221,150,000 shares $340.25 million +12.8%2.6%3.2 $295.87 1/15/20221,020,000 shares $307.24 million -8.1%2.3%3.2 $301.22 12/31/20211,110,000 shares $398.68 million -5.1%2.5%4.1 $359.17 12/15/20211,170,000 shares $369.09 million +26.0%2.6%4.9 $315.46 11/30/2021928,900 shares $292.40 million -6.9%2.1%4.2 $314.78 11/15/2021997,800 shares $347.59 million +22.0%2.2%4.9 $348.36 10/29/2021817,700 shares $271.51 million +1.1%1.8%4 $332.04 10/15/2021809,200 shares $284.33 million -2.1%1.8%4.4 $351.37 9/30/2021826,900 shares $269.17 million -1.1%1.9%4.4 $325.52 9/15/2021836,300 shares $297.04 million -0.5%1.9%4.3 $355.18 8/31/2021840,100 shares $305.76 million +8.0%1.9%4.1 $363.96 8/13/2021777,600 shares $250.12 million +3.5%1.8%3.4 $321.65 7/30/2021751,100 shares $245.71 million -2.4%1.7%3.1 $327.14 7/15/2021769,600 shares $238.72 million -10.3%1.7%3 $310.19 6/30/2021857,500 shares $267.63 million +1.1%1.9%3.2 $312.11 6/15/2021848,100 shares $255.89 million +7.5%1.9%3.2 $301.72 5/28/2021789,000 shares $224.53 million +4.4%1.8%2.9 $284.58 5/14/2021756,100 shares $198.64 million -9.0%1.7%2.7 $262.71 4/30/2021830,600 shares $268.23 million -17.8%1.9%2.9 $322.94 4/15/20211,010,000 shares $333.91 million -14.4%2.3%3.3 $330.60At first glance, this chart looks like nonsense… (Ad)We can isolate the most bullish dates to buy Netflix each and every year… That’s why one former hedge fund manager calls these dates… “Hotspot Dates”But if you want the stock with “Hotspot Dates” hitting NEXT WEEK… ABMD Short Interest - Frequently Asked Questions What is Abiomed's current short interest? Short interest is the volume of Abiomed shares that have been sold short but have not yet been closed out or covered. As of November 30th, investors have sold 753,600 shares of ABMD short. 1.71% of Abiomed's shares are currently sold short. Learn More on Abiomed's current short interest. What is a good short interest ratio for Abiomed? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ABMD shares currently have a short interest ratio of 1.0. Learn More on Abiomed's short interest ratio. What is a good short interest percentage for Abiomed? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.71% of Abiomed's floating shares are currently sold short. Is Abiomed's short interest increasing or decreasing? Abiomed saw a increase in short interest in the month of November. As of November 30th, there was short interest totaling 753,600 shares, an increase of 12.9% from the previous total of 667,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Abiomed's float size? Abiomed currently has issued a total of 45,091,000 shares. Some of Abiomed's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Abiomed currently has a public float of 44,160,000 shares. How does Abiomed's short interest compare to its competitors? 1.71% of Abiomed's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Abiomed: Baxter International Inc. (1.50%), Insulet Co. (4.46%), Teleflex Incorporated (1.89%), ResMed Inc. (5.36%), Globus Medical, Inc. (5.73%), Haemonetics Co. (4.06%), iRhythm Technologies, Inc. (8.19%), NovoCure Limited (5.20%), Nevro Corp. (12.14%), DexCom, Inc. (3.78%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Occidental Petroleum Co. ($3.93 billion), Suncor Energy Inc. ($3.50 billion), T. Rowe Price Group, Inc. ($2.29 billion), PG&E Co. ($1.73 billion), Coinbase Global, Inc. ($1.71 billion), Etsy, Inc. ($1.65 billion), Paramount Global ($1.54 billion), Lucid Group, Inc. ($1.50 billion), Old Dominion Freight Line, Inc. ($1.46 billion), and DICK'S Sporting Goods, Inc. ($1.41 billion). View all of the most shorted stocks. What does it mean to sell short Abiomed stock? Short selling ABMD is an investing strategy that aims to generate trading profit from Abiomed as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Abiomed? A short squeeze for Abiomed occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ABMD, which in turn drives the price of the stock up even further. How often is Abiomed's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ABMD, twice per month. The most recent reporting period available is November, 30 2022. More Short Interest Resources from MarketBeat Related Companies: Baxter International Short Interest Data Insulet Short Interest Data Teleflex Short Interest Data ResMed Short Interest Data Globus Medical Short Interest Data Haemonetics Short Interest Data iRhythm Technologies Short Interest Data NovoCure Short Interest Data Nevro Short Interest Data DexCom Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ABMD) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill Publishingtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals